Meghmani Organics Latest Share Price (MOL)
TODAY IN ONE LINE
MOL fell 2.9% on above-average volume (2.0x avg), lagging Nifty's 0.2% move.
With a market cap of ₹1,589.46 Cr., it trades at a P/E of 23.76. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Meghmani Organics flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Earnings DeclineEPS (TTM) has contracted by 59.0% YoY
- ●Sales ContractionQuarterly sales dropped 14.3% YoY
- ●Poor Capital ReturnsLow ROE of 1.9%
Latest Meghmani Organics News
What changed recently?
Recent events, corporate actions, and announcements.
Meghmani Organics Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Meghmani Organics Limited, framed against the sector median so the premium or discount is obvious at a glance.
Meghmani Organics Limited trades at a P/E of 23.76× and P/B of 0.99×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Meghmani Organics Limited technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for Meghmani Organics Limited — derived from the latest tape, not yesterday's close.
Meghmani Organics Limited last traded at ₹62.55 with an intraday range of ₹61.9–₹64.99 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹62.55| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 70.57 | +8.02 | +12.83% |
| R3 | 67.48 | +4.93 | +7.89% |
| R2 | 66.24 | +3.69 | +5.89% |
| R1 | 64.39 | +1.84 | +2.95% |
| PIVOT | 63.15 | 0.60 | 0.95% |
| CURRENT | 62.55 | — | — |
| S1 | 61.30 | -1.25 | -1.99% |
| S2 | 60.06 | -2.49 | -3.99% |
| S3 | 58.21 | -4.34 | -6.93% |
| S4 | 55.12 | -7.43 | -11.87% |
MOL is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹63.31–₹64.99
Trading Inside opening range
Meghmani Organics Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Meghmani Organics Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
Meghmani Organics Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,589.46 Cr. and reported EPS of ₹1.13.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 2,080 | 2,174 ▲ 4.5% |
| Sales Growth YoY %Derived | 32.78% | 4.53% |
| Other Income | 44 | 96 ▲ 119.8% |
| Total Income | 2,124 | 2,270 ▲ 6.9% |
| 1,264 | 1,326 ▲ 4.9% | |
| Gross ProfitDerived | 816 | 848 ▲ 3.9% |
| Gross Margin %Derived | 39.23% | 39.00% |
| 673 | 671 ▼ 0.3% | |
| EBITDA (Operating Profit)Derived | 143 | 176 ▲ 23.6% |
| OPM %Derived | 6.86% | 8.12% |
| 177 | 211 ▲ 19.0% | |
| Profit Before Tax (PBT) | 9 | 62 ▲ 555.2% |
| 20 | 33 ▲ 65.9% | |
| Effective Tax %Derived | 211.94% | 53.67% |
| Total Profit for Period | -11 | 29 ▲ 371.1% |
| Net Profit (Owner's PAT)Derived | -11 | 29 ▲ 371.1% |
| Net Profit Margin %Derived | -0.51% | 1.32% |
| PAT Growth YoY %Derived | 90.00% | 371.11% |
| Earnings Per Share (EPS ₹) | -0.42 | 1.13 ▲ 369.0% |
| Diluted Shares Outstanding (Cr) | 25 | 25 ▲ 0.0% |
| Share of Profit from Associates/JVs | — | -0 |
| Other Comprehensive Income (Net of Tax) | 1 | 1 ▼ 16.9% |
| Total Expenses (incl. D&A & Interest) | 2,114 | 2,208 ▲ 4.5% |
| Material Cost % of RevenueDerived | 61.82% | 57.39% |
| Employee Cost % of RevenueDerived | 5.50% | 6.23% |
| Other Cost % of RevenueDerived | 26.87% | 24.65% |
| Interest Coverage (x)Derived | 0.50x | 0.63x |
| Period | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|
| Revenue from Operations | 2,498 | 2,553 ▲ 2.2% | 1,566 ▼ 38.6% | 2,080 ▲ 32.8% | 2,174 ▲ 4.5% | |
| Sales Growth YoY %Derived | — | 2.17% | -38.64% | 32.78% | 4.53% | |
| Other Income | 96 | 96 ▼ 0.2% | 38 ▼ 60.8% | 44 ▲ 16.4% | 96 ▲ 119.8% | |
| Total Income | 2,595 | 2,649 ▲ 2.1% | 1,604 ▼ 39.4% | 2,124 ▲ 32.4% | 2,270 ▲ 6.9% | |
1,453 | 1,509 ▲ 3.8% | 1,023 ▼ 32.2% | 1,264 ▲ 23.5% | 1,326 ▲ 4.9% | ||
| Gross ProfitDerived | 1,045 | 1,044 ▼ 0.2% | 543 ▼ 47.9% | 816 ▲ 50.2% | 848 ▲ 3.9% | |
| Gross Margin %Derived | 41.84% | 40.88% | 34.68% | 39.23% | 39.00% | |
667 | 703 ▲ 5.4% | 563 ▼ 19.8% | 673 ▲ 19.5% | 671 ▼ 0.3% | ||
| EBITDA (Operating Profit)Derived | 379 | 341 ▼ 9.9% | -20 ▼ 105.9% | 143 ▲ 804.0% | 176 ▲ 23.6% | |
| OPM %Derived | 15.15% | 13.36% | -1.29% | 6.86% | 8.12% | |
78 | 162 ▲ 106.7% | 139 ▼ 14.2% | 177 ▲ 27.8% | 211 ▲ 19.0% | ||
| Profit Before Tax (PBT) | 409 | 313 ▼ 23.4% | -121 ▼ 138.7% | 9 ▲ 107.8% | 62 ▲ 555.2% | |
104 | 75 ▼ 27.8% | -15 ▼ 120.1% | 20 ▲ 232.5% | 33 ▲ 65.9% | ||
| Effective Tax %Derived | 25.53% | 24.08% | 12.50% | 211.94% | 53.67% | |
| Total Profit for Period | 304 | 238 ▼ 21.9% | -106 ▼ 144.6% | -11 ▲ 90.0% | 29 ▲ 371.1% | |
| Net Profit (Owner's PAT)Derived | 304 | 238 ▼ 21.9% | -106 ▼ 144.6% | -11 ▲ 90.0% | 29 ▲ 371.1% | |
| Net Profit Margin %Derived | 12.18% | 9.31% | -6.77% | -0.51% | 1.32% | |
| PAT Growth YoY %Derived | — | -21.91% | -144.60% | 90.00% | 371.11% | |
| Earnings Per Share (EPS ₹) | 11.97 | 9.35 ▼ 21.9% | -4.17 ▼ 144.6% | -0.42 ▲ 89.9% | 1.13 ▲ 369.0% | |
| Diluted Shares Outstanding (Cr) | 25 | 25 ▲ 0.0% | 25 ▲ 0.0% | 25 ▲ 0.0% | 25 ▲ 0.0% | |
| Share of Profit from Associates/JVs | — | — | — | — | -0 | |
| Other Comprehensive Income (Net of Tax) | 0 | 1 ▲ 86.9% | 1 ▲ 0.4% | 1 ▲ 16.9% | 1 ▼ 16.9% | |
| Total Expenses (incl. D&A & Interest) | 2,186 | 2,336 ▲ 6.8% | 1,725 ▼ 26.1% | 2,114 ▲ 22.5% | 2,208 ▲ 4.5% | |
| Material Cost % of RevenueDerived | 63.94% | 59.49% | 57.68% | 61.82% | 57.39% | |
| Employee Cost % of RevenueDerived | 4.79% | 5.07% | 7.40% | 5.50% | 6.23% | |
| Other Cost % of RevenueDerived | 21.90% | 22.45% | 28.57% | 26.87% | 24.65% | |
| Interest Coverage (x)Derived | 33.57x | 4.02x | -2.43x | 0.50x | 0.63x |
Meghmani Organics segment analysis : revenue and profit mix.
Disclosed business segments at Meghmani Organics with their share of revenue and profit, switchable between consolidated and standalone reporting.
Meghmani Organics discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Meghmani Organics Limited.
Our AI distills the core fundamental drivers supporting Meghmani Organics Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Meghmani Organics Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Quarterly sales surged 48.30% YoY, reflecting robust agrochemical sector demand recovery.
Latest quarterly profit jumped 176% YoY, signaling strong operational turnaround momentum.
Stable promoter holding at 48.95% demonstrates management confidence and strategic alignment.
Positive operating cash flow of ₹66.83 Cr (Q2 FY26) supports liquidity and capex.
Vertically integrated pigments and agrochemicals model offers cost resilience versus peers.
Key Risks.
Latest quarterly EPS declined 59.5% YoY despite revenue growth, margin compression evident.
TTM EPS declined 59.0% YoY, indicating persistent earnings volatility and fundamental weakness.
Extremely low ROE of 1.88% and ROCE of 6.67% reveal poor capital efficiency and returns.
High P/E of 43.23x signals severe overvaluation relative to peer median of 27.31x.
Moderate leverage with D/E of 0.30x (net debt ₹519.59 Cr) raises refinancing risk concerns.
Flip Conditions.
Valuation risk. a P/E above 31 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Meghmani Organics Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Meghmani Organics Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Meghmani Organics Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Meghmani Organics Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Meghmani Organics Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Meghmani Organics Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Meghmani Organics Limited stood at 37.0% of traded volume, against a 20-day average of 43.5%.
Meghmani Organics announcements: results, concalls, ratings, M&A.
Filings Meghmani Organics sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Meghmani Organics files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 92 documents below.
Copy of Newspaper Publication
Meghmani Organics Limited has informed the Exchange about Copy of Newspaper Publication for 7th Annual General Meeting and evoting
Shareholders meeting
Meghmani Organics Limited has informed the Exchange regarding Notice of AGM to be held on September 08, 2026
General Updates
Meghmani Organics Limited has informed the Exchange about Book Closure and Cut off date of 7th Annual General Meeting of the Company
Copy of Newspaper Publication
Meghmani Organics Limited has informed the Exchange about Copy of Newspaper Publication of Pre Advertisement of Annual General Meeting of the Company.
Copy of Newspaper Publication
Meghmani Organics Limited has informed the Exchange regarding the newspaper publication of the notice for the hearing of the Company s petition for…
Investor decks & rating reports.
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Meghmani Organics dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Meghmani Organics has declared, sequenced by announce and record date.
Meghmani Organics corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Meghmani Organics Limited: business, sector, key facts.
What Meghmani Organics Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Meghmani Organics Limited operates in the Pesticides & Agrochemicals industry under the Chemicals sector, listed as NSE: MOL, BSE: 543331.
Meghmani Organics Limited (MOL) is an Indian company primarily engaged in the manufacturing and sale of pigments and agrochemicals, both domestically and internationally. Their core business revolves around providing high-quality products to various industries, showcasing a diverse portfolio and strong presence in multiple sectors.
A significant portion of MOL's business focuses on pigments, specifically green and blue pigments. These pigments find extensive use in a range of applications, including printing inks, paints and coatings, and plastics. The company’s commitment to producing these essential colorants highlights its role in the manufacturing supply chain for diverse industries.
The company's agrochemical division is another major revenue contributor. MOL produces a comprehensive line of insecticides, encompassing a broad spectrum of active ingredients such as acetamiprid, alphacypermethrin, and many others. This wide range allows them to cater to various pest control needs across different agricultural settings and crop types.
Beyond insecticides, MOL also manufactures herbicides, including formulations of 2,4-D and triclopyr. The company's involvement extends to the production of crucial intermediates used in the synthesis of these agrochemicals, demonstrating a vertically integrated approach to production and supply.
Further bolstering its chemical offerings, MOL produces and supplies anatase and grade titanium dioxide. This versatile material finds application in a remarkably wide array of sectors, ranging from paints and coatings to plastics, polymers, inks, dyes, paper, and even cosmetics, underscoring the broad reach of their product portfolio.
In summary, MOL operates across multiple interconnected chemical sectors, showcasing both breadth and depth in its product offerings. Their integrated approach, from the production of intermediates to the manufacturing of finished goods across pigments and agrochemicals, demonstrates a robust business model focused on providing essential materials to a wide range of industries.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Astec LifeSciences (ASTEC) Share PricePeer
- Bhagiradha Chemicals & Industries (BHAGCHEM) Share PricePeer
- Bharat Rasayan (BHARATRAS) Share PricePeer
- Dhanuka Agritech (DHANUKA) Share PricePeer
- Dharmaj Crop Guard (DHARMAJ) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Meghmani Organics Limited (MOL).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Meghmani Organics Limited (MOL)?
The current share price of Meghmani Organics Limited (MOL) is ₹62.55. Today, the stock has declined by ₹1.88 (2.92%), trading in a range of ₹61.90 to ₹64.99. The stock opened at ₹64.36 with a trading volume of 14,40,882 shares.
02Is Meghmani Organics Limited stock a good investment for long-term?
Meghmani Organics Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,589.46 Cr., P/E ratio of 23.76, ROE of 1.88%, and ROCE of 6.67%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Meghmani Organics Limited stock?
The 52-week high price of Meghmani Organics Limited (MOL) is ₹87.75, while the 52-week low is ₹36.50. Currently trading at ₹62.55, the stock is 71.37% above its 52-week low and 28.72% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Meghmani Organics Limited stock at the current price?
Whether to buy Meghmani Organics Limited stock at ₹62.55 depends on multiple factors. The stock is currently trading with a P/E ratio of 23.76 and P/B ratio of 0.99. Today's performance shows a loss of 2.92%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Meghmani Organics Limited and when is the next dividend?
Meghmani Organics Limited offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹62.55, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Meghmani Organics Limited?
Meghmani Organics Limited's key financial metrics include: P/E Ratio: 23.76, P/B Ratio: 0.99, ROE: 1.88%, ROCE: 6.67%, Dividend Yield: 0%, EPS: ₹1.13, Book Value: ₹61.55, and Debt-to-Equity: 0.47. The company's market cap stands at ₹1,589.46 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Meghmani Organics Limited stock performing today in the market?
Meghmani Organics Limited stock opened at ₹64.36 and is currently trading at ₹62.55, showing a decline of ₹1.88 (2.92%). The intraday high is ₹64.99 and low is ₹61.90. The trading volume stands at 14,40,882 shares, indicating strong market participation today.
08What is the P/E ratio of Meghmani Organics Limited and what does it indicate?
Meghmani Organics Limited has a Price-to-Earnings (P/E) ratio of 23.76, which means investors are willing to pay 23.76 for every ₹1 of earnings. With an EPS of ₹1.13, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Meghmani Organics Limited (MOL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.